UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000048868
Receipt number R000055321
Scientific Title A Standardized Approach for the Rater Training Program in the Action Research Arm Test
Date of disclosure of the study information 2022/09/12
Last modified on 2023/03/13 14:49:50

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effect of Training on Accuracy and Variance of Action Research Arm Test Scoring

Acronym

Effect of Training on Accuracy of ARAT Scoring

Scientific Title

A Standardized Approach for the Rater Training Program in the Action Research Arm Test

Scientific Title:Acronym

A Standardized Approach for the ARAT Training Program

Region

Japan


Condition

Condition

Stroke

Classification by specialty

Rehabilitation medicine Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

(1) To develop a standardized approach for the rater training program in the action research arm test.
(2) To investigate inter-rater reliability in stroke patients using the developed standardized approach to the action research arm test.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Japanese version of the Action Research Arm Test

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

100 years-old >

Gender

Male and Female

Key inclusion criteria

Patients with (incomplete) upper extremity paresis resulting from stroke are included.

Key exclusion criteria

Exclusion criteria include the following: (1) clear sign of dementia; (2) mental di sorder, or aphasia as an obstacle to dail y living; (3) excessive pain; (4) the sever e end-stage or uncontrolled medical co nditions.

Target sample size

30


Research contact person

Name of lead principal investigator

1st name Satoru
Middle name
Last name Amano

Organization

Kitasato University

Division name

Rehabilitation

Zip code

252-0373

Address

1-15-1, Kitasato, Minami-ku, Sagamihara Kanagawa, JAPAN

TEL

042-778-8111

Email

s-amano@st.kitasato-u.ac.jp


Public contact

Name of contact person

1st name Hikaru
Middle name
Last name Yamaoka

Organization

Shonan-Keiiku Hospital

Division name

Department of rehbabilitation

Zip code

252-0816

Address

4360, Endo, Fujisawa, Kanagawa

TEL

0466-48-0050

Homepage URL


Email

yamaoka.h.ot@gmail.com


Sponsor or person

Institute

Kitasato University

Institute

Department

Personal name



Funding Source

Organization

Kitasato University

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Shonan-Keiiku Hospital

Address

4360, Endo, Fujisawa, Kanagawa

Tel

0466-48-0050

Email

yamaoka.h.ot@gmail.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2022 Year 09 Month 12 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

30

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2021 Year 12 Month 24 Day

Date of IRB

2022 Year 01 Month 25 Day

Anticipated trial start date

2022 Year 12 Month 01 Day

Last follow-up date

2023 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

For the analysis of inter-rater reliability, the total score was assessed using ICCs. The two-way random approach (ICC 2, 1) with absolute agreement was used to compare video observation assessments. The inter-rater reliability of individual item scores was assessed using the weighted kappa coefficient. A Bland-Altman plot was used to assess the magnitude and direction of bias (mean difference and limits of agreements) in measurement agreement between raters.

Sample size was determined using Bonett's methods. A sample size of 28 patients was necessary for a reliability study with two raters, an intraclass correlation planning value of 0.8, a desired precision width of 0.15, and an alpha equal to 0.05.


Management information

Registered date

2022 Year 09 Month 07 Day

Last modified on

2023 Year 03 Month 13 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000055321


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name